The neuropeptide Y/neuropeptide Y receptor system promotes BC cell proliferation, migration, invasion and metastasis and angiogenesis, whereas neuropeptide Y receptor antagonists inhibit all these effects and favor the death of tumor cells [188]. This evidence concerns the gene NPY and breast cancer.